The DOI matches its Crossref record; 211 of the 211 references it cites were found in a registry or an index.
When astrocytes become harmful: Functional and inflammatory responses that contribute to Alzheimer's disease
Abstract
A growing body of research suggests that astrocytes play roles as contributors to the pathophysiology of Alzheimer's disease (AD). Several lines of evidence propose that activated astrocytes produce and release proinflammatory molecules that may be critical for the generation of amyloid-β peptide (Aβ). However, accumulating evidence indicates that Aβ may activate astrocytes, which leads to an increase in cytokines that has been suggested to be a causative factor in the cognitive dysfunction of AD; thus, a vicious circle may be created. Intrinsic inflammatory mechanisms may provide a regulatory system that is capable of influencing the neuronal microenvironment that affects neuronal survival. In this article, we address the evidence surrounding the interactions of dysfunctional astrocytes with neighboring neurons that may initiate a cascade of events that culminates with neuronal injury and the expression of the hallmark lesions of AD. Comprehensive knowledge of the molecular mechanisms underlying the participation of astrocytes in neurodegeneration could aid the development of therapies to restore proper astrocyte function that can be used in AD patients to prevent or alleviate the progression of the disease in a more efficient and comprehensive manner.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Recent evidence suggests that reactive astrocytes also contribute to neuroinflammatory processes associated with AD pathology [93].”
From Tau and neuroinflammation in Alzheimer’s disease: interplay mechanisms and clinical translation (2023) · cites this paper as [93]
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Glutamate neurotoxicity and diseases of the nervous system
Choi, D. W. (1988) · Neuron · doi:10.1016/0896-6273(88)90162-6 · Cited by 8,184
Astrocytes: Biology and pathology
Sofroniew, M. V., & Vinters, H. V. (2010) · Acta Neuropathologica · doi:10.1007/s00401-009-0619-8 · Cited by 5,196
Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASE
DAVIES, P. (1976) · The Lancet · doi:10.1016/s0140-6736(76)91936-x · Cited by 3,565
Neurovascular pathways to neurodegeneration in Alzheimer’s disease and other disorders
Zlokovic, B. V. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3114 · Cited by 2,969
Tripartite synapses: glia, the unacknowledged partner
Araque, A., Parpura, V., Sanzgiri, R. P., & Haydon, P. G. (1999) · Trends in Neurosciences · doi:10.1016/s0166-2236(98)01349-6 · Cited by 2,529
Glial and neuronal control of brain blood flow
Attwell, D., Buchan, A. M., Charpak, S., Lauritzen, M., MacVicar, B. A., & Newman, E. A. (2010) · Nature · doi:10.1038/nature09613 · Cited by 2,511
Silent Brain Infarcts and the Risk of Dementia and Cognitive Decline
Vermeer, S. E., Prins, N. D., den Heijer, T., Hofman, A., Koudstaal, P. J., & Breteler, M. M. B. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022066 · Cited by 2,313
Dementia: a public health priority
Acosta, D. M., Krishnamoorthy, E. S., Wortmann, M., Prince, M. J., & Saxena, S. (2012) · Cited by 1,955
Flagged first, then by citations
Research works printed but not linked: 1
- Zou, 2010, Glutamine synthetase down-regulation reduces astrocyte protection against glutamate excitotoxicity to neurons, Neurochem. Int., 56, 577, 10.1016/j.neuint.2009.12.021 · DOI · Paper page
Cited by
Sorted by citations
Items 101–114 of 114
Yoon, S., & Kim, Y. (2015) · Global Medical Genetics · doi:10.3934/genet.2015.3.230 · Cited by 5
What do we know about the risks of developing dementia after traumatic brain injury?
Raymont, V., & Thayanandan, T. (2021) · Minerva Medica · doi:10.23736/s0026-4806.20.07084-6 · Cited by 2
Mechanisms to medicines: navigating drug repurposing strategies in Alzheimer’s disease
Khan, S. A., Raza, K., Tiwari, P., El‐Tanani, M., Rabbani, S. A., & Parvez, S. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1676065 · Cited by 1
Peripheral biomarkers of neuroinflammation in Alzheimer’s disease and vascular dementia
Ouyang, X., Chia, R. S. L., Chai, Y. L., Chong, Sim, M. A., Jo, D., Arumugam, T. V., Sethi, G., Dawe, G. S., Chen, C. P., et al. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.118077 · Cited by 1
Jana, A., Narasipura, S. D., Szczerkowski, J. L. A., Mamede, J. I., & Al‐Harthi, L. (2026) · Journal of Neuroinflammation · doi:10.1186/s12974-026-03886-0 · Cited by 1
Bong, S., Choi, H., Song, H., Kim, D. K., Mook‐Jung, I., & Lee, D. Y. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70030 · Cited by 1
Deconstructing Neuronal and Astroglial Contributions to Sleep and Inflammatory Immune Responses.
Ingiosi, A. M. (2015) · Deep Blue (University of Michigan)
Farnsworth, B. (2016) · KTH Publication Database DiVA (KTH Royal Institute of Technology)
Munger, E. L. (2016) · OhioLink ETD Center (Ohio Library and Information Network)
Investigating neurobiological mechanisms linking depression and inflammation
Hasebe, K. (2017) · Figshare
Yan, R. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.738448428.793577747
Physical Activity and the Myokine Irisin in Non-pharmacological Treatment of Alzheimer Disease
Gibizov, Y. A., Vagapova, L. B., Aguzarova, A. O., Nazarova, J. V., Zotkina, Y. A., Atamanyuk, E. A., Rodikova, M. M., Timergaleev, R. N., Kupriyanov, A. M., Chuprina, A. A., et al. (2025) · Russian Journal of Physiotherapy Balneology and Rehabilitation · doi:10.17816/rjpbr677844
Advances in neurotherapeutics for neurodegeneration
Kapur, D., Vashisht, D., & Singh, T. (2026) · Discover Neuroscience · doi:10.1186/s13064-026-00279-0
Metadata
- Authors
- Avila-Muñoz, E., & Arias, C.
- Affiliations
- Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México (MX)
- Corresponding author
- Arias, Clorinda
- ORCID
- Arias, Clorinda
- Venue
- Ageing Research Reviews
- Publisher
- Elsevier BV
- Published
- 2014-11
- Volume
- 18
- Pages
- 29-40
- ISSN
- 1568-1637 (ISSN-L)
- OpenAlex
- W2017431945
- Cited by
- 114
- References
- 211
- Citations by year
- 2026: 4 · 2025: 9 · 2024: 3 · 2023: 7 · 2022: 3 · 2021: 13 · 2020: 10 · 2019: 6 · 2018: 10 · 2017: 8 · 2016: 19 · 2015: 20 · 2014: 2
- FWCI
- 1.91
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Ageing Research Reviews (publishedVersion)
- PubMed (publishedVersion)
- Funders
- CONACYT (166482, 239696)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- astrocytes, Alzheimer's disease, neuroinflammation, amyloid-beta, cytokines, astrocyte-neuron interaction, neurodegeneration, cognitive impairment, neuronal injury, astrocyte dysfunction
- MeSH terms
- Alzheimer Disease, Animals, Astrocytes, Humans, Inflammation, Neurons, Signal Transduction, Amyloid beta-Peptides, Inflammation Mediators, Paracrine Communication
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review